Szymczak Aleksandra, Simon Krzysztof, Inglot Malgorzata, Gladysz Andrzej
Department of Infectious Diseases, Wroclaw Medical University, Wroclaw, Poland.
Hepat Mon. 2012 Jan;12(1):32-7. doi: 10.5812/kowsar.1735143x.4388. Epub 2012 Jan 20.
Percutaneous liver biopsy is one of the most important and widely used methods for diagnosing chronic liver diseases; however, controversies related to the potential risk of complications and patient discomfort still exist.
The objective of this study was to evaluate the safety and success rate of blind percutaneous liver biopsy.
We conducted a retrospective analysis of 1412 blind percutaneous thick-needle liver biopsies performed during 1977-2000 at a single center on 1110 patients, using archived medical data of the center.
The overall success rate of obtaining a liver sample with this method was 95.3%. Of all the samples assessed, 91.7% were determined to be fully representative for an evaluation by the pathologist. Complications occurred in 259 procedures (18.3%). While no fatalities associated with liver biopsy were noted, 9 serious complications (0.64%) directly related to biopsies were reported. Pain was the most common complication (15.3%). Significantly more complications (pain and vasovagal reactions) were reported in females (22.1%) than in males (16.1%) (P = 0.005). The rate of complications was significantly correlated with the stage of fibrosis (P = 0.027), i.e. the higher the fibrosis stage, the higher the complication rate. Previous surgical procedures involving the abdominal cavity or thorax influenced the effectiveness of liver biopsy (P = 0.017). Less operator experience was significantly associated with a higher rate of procedure failure (P = 0.002). Statistical significance of the relationship between individual operator efficiency and complication rate (P = 0.000) and that between individual operator efficiency and biopsy failure rate (P = 0.002) was observed.
Blind percutaneous liver biopsy is a safe and effective invasive procedure, despite the fact that noninvasive fibrosis assessment methods are currently widely available and used instead of histological evaluation. Complications risk and failure rate are low if indications and contraindications are considered carefully and the biopsy is performed by a skilled and experienced operator. Certain groups of patients may benefit from an image-guided procedure to improve its effectiveness.
经皮肝穿刺活检是诊断慢性肝病最重要且应用最广泛的方法之一;然而,与潜在并发症风险和患者不适相关的争议依然存在。
本研究的目的是评估盲目经皮肝穿刺活检的安全性和成功率。
我们利用该中心的存档医疗数据,对1977年至2000年期间在单一中心对1110例患者进行的1412例盲目经皮粗针肝穿刺活检进行了回顾性分析。
用该方法获取肝组织样本的总体成功率为95.3%。在所有评估的样本中,91.7%被病理学家判定为完全具有代表性可供评估。259例操作(18.3%)出现并发症。虽然未观察到与肝活检相关的死亡病例,但报告了9例与活检直接相关的严重并发症(0.64%)。疼痛是最常见的并发症(15.3%)。女性报告的并发症(疼痛和血管迷走神经反应)显著多于男性(22.1%对16.1%)(P = 0.005)。并发症发生率与纤维化阶段显著相关(P = 0.027),即纤维化阶段越高,并发症发生率越高。既往涉及腹腔或胸腔的手术操作影响肝活检的有效性(P = 0.017)。术者经验较少与操作失败率较高显著相关(P = 0.002)。观察到个体术者效率与并发症发生率之间关系的统计学显著性(P = 0.000)以及个体术者效率与活检失败率之间关系的统计学显著性(P = 0.002)。
盲目经皮肝穿刺活检是一种安全有效的侵入性操作,尽管目前广泛可得且使用非侵入性纤维化评估方法替代组织学评估。如果仔细考虑适应证和禁忌证并由熟练且经验丰富的术者进行活检,并发症风险和失败率较低。某些患者群体可能受益于影像引导操作以提高其有效性。